APP and Alzheimer disease: Aβ, derived from the proteolytic cleavage of amyloid precursor protein (APP), progressively aggregates into neurotoxic plaques, leading to mitochondrial dysfunction, synaptic impairment, and neuronal death, thereby driving the onset and progression of AD [48].